A spokesperson for CVS said the corporation is also experiencing the shortage of the Shingrix vaccine, which is about 96 percent effective in preventing the shingles virus.
A spokesperson for CVS said the corporation is also experiencing the shortage of the Shingrix vaccine, which is about 96 percent effective in preventing the shingles virus. Gene J. Puskar AP
A spokesperson for CVS said the corporation is also experiencing the shortage of the Shingrix vaccine, which is about 96 percent effective in preventing the shingles virus. Gene J. Puskar AP

CVS set to buy Aetna for $69 billion in deal that could shake up healthcare industry

December 03, 2017 09:22 PM